Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice.
about
Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?Murine model and mechanisms of treatment-induced painful diabetic neuropathy.
P2860
Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of a long-acting C-pe ...... streptozotocin-diabetic mice.
@en
type
label
Efficacy of a long-acting C-pe ...... streptozotocin-diabetic mice.
@en
prefLabel
Efficacy of a long-acting C-pe ...... streptozotocin-diabetic mice.
@en
P2093
P2860
P356
P1476
Efficacy of a long-acting C-pe ...... streptozotocin-diabetic mice.
@en
P2093
C G Jolivalt
M Rodriguez
N A Calcutt
P2860
P304
P356
10.1111/DOM.12477
P50
P577
2015-04-23T00:00:00Z